These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11783133)

  • 41. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The efficacy of alendronate in the prevention and treatment of postmenopausal osteoporosis].
    Cheng ZQ; Yin W; Fan JY; Ma TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):306-9. PubMed ID: 12905641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss. Coadjuvant use with hormone replacement therapy.
    Castelo-Branco C; Martínez de Osaba MJ; Pons F; Casals E; Sanjuán A; Vicente JJ; Vanrell JA
    J Reprod Med; 1999 Mar; 44(3):241-6. PubMed ID: 10202741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The avoidance of early postmenopausal bone substance losses by transdermal estrogen substitution].
    Ringe JD; Meiss F
    Dtsch Med Wochenschr; 1993 May; 118(21):769-74. PubMed ID: 8504712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A one-year prospective study of disodium etidronate versus 17 beta estradiol in the prevention of postmenopausal osteoporosis].
    Chaouat D; Belange G; Danan S; De Vernejoul MC; Faures Quenet B; Chaouat Y
    Rev Rhum Ed Fr; 1993 May; 60(5):353-8. PubMed ID: 8167642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histomorphometric changes in the skeleton of postmenopausal women with low bone mineral density treated with percutaneous estradiol implants.
    Holland EF; Chow JW; Studd JW; Leather AT; Chambers TJ
    Obstet Gynecol; 1994 Mar; 83(3):387-91. PubMed ID: 8127530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteoporosis prevention clinical study program.
    Delmas P; Gimona A
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.
    Garnett T; Studd J; Watson N; Savvas M; Leather A
    Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Jurvelin J; Saarikoski S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss.
    Bjarnason NH; Byrjalsen I; Hassager C; Haarbo J; Christiansen C
    Am J Obstet Gynecol; 2000 Sep; 183(3):550-60. PubMed ID: 10992173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women.
    Reinhardt RA; Payne JB; Maze CA; Patil KD; Gallagher SJ; Mattson JS
    J Periodontol; 1999 Aug; 70(8):823-8. PubMed ID: 10476887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
    Yoldemir T; Erenus M; Durmusoglu F
    Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
    Grey AB; Cundy TF; Reid IR
    Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
    Rubinacci A; Peruzzi E; Modena AB; Zanardi E; Andrei B; De Leo V; Pansini FS; Quebe-Fehling E; de Palacios PI
    Menopause; 2003; 10(3):241-9. PubMed ID: 12792297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prevention of bone loss by estradiol valerate combined with medroxyprogesterone acetate among postmenopausal women with osteopenia].
    Lu J; Lin S; Zhang L; Yu W; Shen Y; Zhang Y; Chen F
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1593-8. PubMed ID: 12667363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group.
    Weiss SR; Ellman H; Dolker M
    Obstet Gynecol; 1999 Sep; 94(3):330-6. PubMed ID: 10472854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.